AB011

· CARsgen Therapeutics Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AB011, covering 2024-05-24 to 2024-05-24. Get the full timeline:

Most recent: Clinical Trial Update: Clinical Trial to Evaluate AB011 Injection in Patients With CLDN18.2-positive Advanced Solid Tumors [Phase 1]